Chemoprevention with special reference to inherited colorectal cancer

Familial Cancer

Volumn 7, Issue 1, 2008, Pages 59-64

  Lynch, Patrick M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Celecoxib; Chemoprevention; Colorectal adenomas; Colorectal cancer; COX 2 inhibition; Familial adenomatous polyposis; Rofecoxib; Sulindac

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2; EFLORNITHINE; NONSTEROID ANTIINFLAMMATORY AGENT; QUERCETIN; ROFECOXIB; STARCH; SULINDAC; SULINDAC SULFONE; TRACE ELEMENT; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; LACTONE; PYRAZOLE DERIVATIVE; SULFONAMIDE; SULFONE; VITAMIN;

CARDIOTOXICITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; EVENING DOSAGE; FAMILIAL ADENOMATOUS POLYPOSIS; FAMILIAL CANCER; GENE MUTATION; HUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UNSPECIFIED SIDE EFFECT; ARTICLE; COLON POLYPOSIS; COLORECTAL TUMOR; DIET THERAPY; DRUG COMBINATION; GENETICS; METHODOLOGY;

ADENOMATOUS POLYPOSIS COLI; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; CHEMOPREVENTION; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; CURCUMIN; CYCLOOXYGENASE 2 INHIBITORS; DRUG THERAPY, COMBINATION; EFLORNITHINE; HUMANS; LACTONES; PYRAZOLES; SULFONAMIDES; SULFONES; SULINDAC; VITAMINS;

EID: 46449094710     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9158-4     Document Type: Conference Paper

References (28)

1. WR Waddell RW Loughry 1983 Sulindac for polyposis of the colon J Surg Oncol 24 83 87
2. D Labayle D Fischer P Viehl 1991 Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 635 639
3. FM Giardello SR Hamilton AJ Krush 1993 Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis NEJM 328 1313 1316
4. M Cruz-Correa LM Hylind K Romans 2002 Long term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 3 641 645
5. G Winde HG Gumbinger F Kemper 1993 The NSAID sulindac reverses rectal adenomas in colectomised patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration Int J Colorectal Dis 8 1 13 17
6. T Matsumoto S Nakamura M Esaki 2006 Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis J Gastro Hepatol 21 251 257
7. I Guldenschuh R Hurlimannn A Muller 2001 Relationship between APC genotype, polyp distribution and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis Dis Colon Rectum 44 8 1090 1097
8. CS Richard T Berk BV Bapat 1997 Sulindac for periampullary polyps in FAP patients Int J Colorectal Dis 12 1 14 18
9. HS Debinski J Trojan KP Nugent 1995 Effect of sulindac on small polyps in familial adenomatous polyposis Lancet 345 855 866
10. KP Nugent KCR Farmer AD Spigelman 1993 Randomized controlled trial of the effects of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis Br J Surg 80 1618 1619
11. AG Thorson HT Lynch TC Smyrk 1994 Rectal cancer in FAP patient after sulindac Lancet 343 417 418
12. FM Giardiello VW Yang LM Hylind 2002 Primary chemoprevention of familial adenomatous polyposis with sulindac NEJM 346 14 1085 1087
13. T Akasu T Yokoyama K Sugihara 2002 Peroral sustained release indomethacin treatment for rectal adenomas in familial adenomatous polyposis: a pilot study Hepatogastroenterology 49 1259 1261
14. M Oshima JE Dinchuk SL Kargman 1996 Suppression of intestinal polyposis in APCΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 809
15. M Wallace PM Lynch 2006 The current status of chemoprevention in FAP Fam Cancer 5 289 294
16. GD Steinbach PM Lynch RKS Phillips 2000 The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946 1952
17. RKS Phillips MH Wallace PM Lynch 2002 A randomized double blind placebo controlled study of celecoxib, a selective cyclooxygenase -2 inhibitor on duodenal polyposis in familial adenomatous polyposis Gut 50 657 660
18. SD Solomon JJV McMurray MA Pfeffer 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention NEJM 352 1071 1080
19. RS Bresalier RS Sandler H Quan 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial NEJM 352 1092 1102
20. N Arber CJ Eagle J Spicak 2006 Celecoxib for the prevention of colorectal adenomatous polyps NEJM 355 885 895
21. JA Baron RS Sander RS Bresalier 2006 A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas Gastro 131 1674 1682
22. MM Bertagnolli CJ Eagle AG Zauber 2006 Celecoxib for the prevention of sporadic colorectal adenomas NEJM 355 873 884
23. A Hallak L Baron R Samir 2003 Rofecoxib reduces polyp recurrence in familial polyposis Dig Dis Sci 49 10 1998 2002
24. R Van Stolk G Stoner WL Hayton 2000 Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis Clin Cancer Res 6 1 78 89
25. Di Sario JA, Ogura MM, Szabo A et al (2005) Exisulind for duodenal adenomas in persons with familial adenomatous polyposis. Gastro (Abst) W970, P A-567
26. HJ Bussey JJ DeCosse EE Deschner 1982 A randomized trial of ascorbic acid in polyposis coli Cancer 50 7 1434 1439
27. JJ DeCosse HH Miller ML Lesser 1989 Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis J Natl Cancer Inst 81 17 1290 1297
28. M Cruz-Correa DA Shoskes P Sanchez 2006 Combination treatment with curcumin and quercitin of adenomas in familial adenomatous polyposis Clin Gastroenterol Hepatol 4 1035 1038